Medivir

1,90 SEK

-1,24%

Mindre end 1K følgere

MVIR

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Værdiansættelse

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Medivir

EV/S

Medianen 2019-2025

P/B

Medianen 2019-2025

 
2019202020212022202320242025
Aktiekurs (SEK)8,345,589,188,112,852,840,41
Aktier36,136,164,468,0104,5112,2448,7
Markedsværdi301,2201,6591,4551,8297,8318,6183,5
Enterprise value166,6131,6370,2426,0128,2256,164,3
EV/S19,19,514,596,816,973,27,6
EV/EBITDAneg.neg.neg.neg.neg.neg.neg.
EV/EBITneg.neg.neg.neg.neg.neg.neg.
P/Eneg.neg.neg.neg.neg.neg.neg.
P/B1,631,422,102,861,372,760,69
P/S34,614,523,2125,439,291,021,6
Udbytteprocent0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %
Equity ratio62,8 %74,1 %83,7 %82,3 %75,7 %66,9 %86,3 %
Gearing ratio-------